Raily Aesthetic Medicine International Holdings Limited (HK:2135) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Raily Aesthetic Medicine International Holdings Limited announced the disposal of its subsidiary, Jiumei Xinhe, resulting in an estimated net loss of RMB740.55. The proceeds from this transaction will be utilized as general working capital for the company. This move reflects the company’s strategic adjustments amidst challenging financial conditions.
For further insights into HK:2135 stock, check out TipRanks’ Stock Analysis page.